Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 4

Research Article

Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial

Table 4

Comparison of survival between the two groups.

Shenfu (%)Controls (%) value

7 d
All patients mortality
 Alive81 (82.7)76 (82.6)0.994
 Dead17 (17.3)16 (17.4)
 Total (lost)98 (4)92 (5)
Mortality of patients with arterial lactate ≥4.5 mmol/L
 Alive20 (83.3)12 (54.5)0.034
 Dead4 (16.7)10 (45.5)
 Total (lost)24 (2)22 (3)
Mortality of patients with arterial lactate <4.5 mmol/L
 Alive61 (82.4)64 (91.4)0.111
 Dead13 (17.6)6 (8.6)
 Total (lost)74 (2)70 (2)
28 d
All patients mortality
 Alive59 (72.0)58 (69.9)0.770
 Dead23 (28.0)25 (30.1)
 Total (lost)82 (20)83 (14)
Mortality of patients with arterial lactate ≥4.5 mmol/L
 Alive16 (72.7)10 (47.6)0.092
 Dead6 (27.3)11 (52.4)
 Total (lost)22 (4)21 (4)
Mortality of patients with arterial lactate <4.5 mmol/L
 Alive43 (71.7)48 (77.4)0.466
 Dead17 (28.3)14 (22.6)
 Total (lost)60 (16)62 (10)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.